JP2023513800A5 - - Google Patents
Info
- Publication number
- JP2023513800A5 JP2023513800A5 JP2022549159A JP2022549159A JP2023513800A5 JP 2023513800 A5 JP2023513800 A5 JP 2023513800A5 JP 2022549159 A JP2022549159 A JP 2022549159A JP 2022549159 A JP2022549159 A JP 2022549159A JP 2023513800 A5 JP2023513800 A5 JP 2023513800A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- cdr
- sequence number
- seq
- clone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062977658P | 2020-02-17 | 2020-02-17 | |
| US62/977,658 | 2020-02-17 | ||
| PCT/US2021/018276 WO2021167915A1 (en) | 2020-02-17 | 2021-02-17 | Human 4-1bb agonist antibodies and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023513800A JP2023513800A (ja) | 2023-04-03 |
| JP2023513800A5 true JP2023513800A5 (https=) | 2024-02-21 |
| JP7840569B2 JP7840569B2 (ja) | 2026-04-06 |
Family
ID=77391204
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549159A Active JP7840569B2 (ja) | 2020-02-17 | 2021-02-17 | ヒト４－１ｂｂアゴニスト抗体およびその使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230092390A1 (https=) |
| EP (1) | EP4106880A4 (https=) |
| JP (1) | JP7840569B2 (https=) |
| KR (1) | KR20220143904A (https=) |
| CN (1) | CN115335123B (https=) |
| AU (1) | AU2021224793A1 (https=) |
| CA (1) | CA3167218A1 (https=) |
| WO (1) | WO2021167915A1 (https=) |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040058445A1 (en) * | 2001-04-26 | 2004-03-25 | Ledbetter Jeffrey Alan | Activation of tumor-reactive lymphocytes via antibodies or genes recognizing CD3 or 4-1BB |
| CA2434668A1 (en) * | 2003-07-04 | 2005-01-04 | Laurence Mulard | Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| WO2007127476A2 (en) * | 2006-04-28 | 2007-11-08 | Oregon Health & Science University | Monoclonal antibodies specific for pancreatic endocrine, exocrine or ductal cell |
| US20090297530A1 (en) * | 2006-05-22 | 2009-12-03 | Feng Wang-Johanning | Herv-k antigens, antibodies, and methods |
| AU2010231575B2 (en) * | 2009-03-30 | 2013-09-12 | Edimer Biotech S.A. | Preparation of isolated agonist anti-EDAR monoclonal antibodies |
| US20140086913A1 (en) * | 2012-09-24 | 2014-03-27 | Gilead Sciences, Inc. | Anti-ddr1 antibodies |
| UY35148A (es) * | 2012-11-21 | 2014-05-30 | Amgen Inc | Immunoglobulinas heterodiméricas |
| US9469686B2 (en) * | 2013-03-15 | 2016-10-18 | Abbott Laboratories | Anti-GP73 monoclonal antibodies and methods of obtaining the same |
| BR112016008477A2 (pt) * | 2013-10-18 | 2017-10-03 | Genentech Inc | Corpos, ácido nucleico, célula hospedeira, método de produção de um anticorpo, imunoconjugado, formulação farmacêutica e usos do anticorpo |
| JP2016538275A (ja) * | 2013-11-04 | 2016-12-08 | グレンマーク ファーマシューティカルズ， エセ．アー． | Ｔ細胞再標的化ヘテロ二量体免疫グロブリン（ｈｅｔｅｒｏ−ｄｉｍｅｒｉｃ ｉｍｍｕｎｏｇｌｏｂｕｌｉｎ）の製造 |
| GB201410520D0 (en) * | 2014-06-12 | 2014-07-30 | Univ London Queen Mary | Antibody |
| US20180030118A1 (en) * | 2015-02-19 | 2018-02-01 | Emergent Biosolutions Canada Inc. | Humanzied filovirus antibodies and uses thereof |
| WO2017205745A1 (en) * | 2016-05-27 | 2017-11-30 | Abbvie Biotherapeutics Inc. | Anti-4-1bb antibodies and their uses |
| MX2019008221A (es) * | 2017-01-10 | 2019-12-09 | Univ Yamaguchi | Anticuerpo anti-gpc3. |
| KR20200113228A (ko) * | 2018-01-22 | 2020-10-06 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 항-4-1bb 항체, 이의 항원-결합 단편 및 이의 의학적 용도 |
| GB201811404D0 (en) * | 2018-07-12 | 2018-08-29 | F Star Beta Ltd | Anti-CD137 Antibodies |
-
2021
- 2021-02-17 JP JP2022549159A patent/JP7840569B2/ja active Active
- 2021-02-17 KR KR1020227032308A patent/KR20220143904A/ko active Pending
- 2021-02-17 CN CN202180023415.9A patent/CN115335123B/zh active Active
- 2021-02-17 US US17/904,459 patent/US20230092390A1/en active Pending
- 2021-02-17 EP EP21757958.0A patent/EP4106880A4/en active Pending
- 2021-02-17 CA CA3167218A patent/CA3167218A1/en active Pending
- 2021-02-17 AU AU2021224793A patent/AU2021224793A1/en active Pending
- 2021-02-17 WO PCT/US2021/018276 patent/WO2021167915A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113603783B (zh) | 蛋白酶可切割的双特异性抗体及其用途 | |
| EP3237006B1 (en) | Bispecific tetravalent antibodies and methods of making and using thereof | |
| CN103987731B (zh) | Agr2阻断抗体及其用途 | |
| JP2022031784A5 (https=) | ||
| JP2023539501A5 (https=) | ||
| JP2021508469A5 (https=) | ||
| WO2018133842A1 (zh) | 人程序性死亡受体pd-1的单克隆抗体及其片段 | |
| JP2022512891A5 (https=) | ||
| CN116948035A (zh) | 多特异性抗体及其制备和使用方法 | |
| JP2022550243A5 (https=) | ||
| JP2022545741A5 (https=) | ||
| CN113574069A (zh) | 抗pd-l1抗体及其用途 | |
| US20230340119A1 (en) | Composition of triax antibodies and method of making and using thereof | |
| JP2024519078A5 (https=) | ||
| JP2023513800A5 (https=) | ||
| WO2018027147A1 (en) | Affinity maturated tag72 specific single chain antibodies | |
| EP4417622A1 (en) | Anti-cd26 antibody and use thereof | |
| JP2024528987A5 (https=) | ||
| WO2023143273A1 (zh) | 新型长效化和高活性且更安全的抗体构建体 | |
| TW202146446A (zh) | 一種抗pd-l1和egfr的四價雙特異性抗體 | |
| JP2024508597A5 (https=) | ||
| WO2024152963A1 (zh) | 抗cd3的人源化抗体及其应用 | |
| HK40128165A (zh) | Triax抗体的组合物及其制备和使用方法 | |
| HK40128164A (zh) | Triax抗体的组合物及其制备和使用方法 | |
| WO2024037627A1 (zh) | 一种双特异性抗体及其应用 |